When a cannabis company loses a lot of money every quarter, and has to sell real estate, cancel acquisitions, lay off staff, renegotiate existing financing… Read More »This is an actual MedMen (MMEN.C) news release
Like the old Twilight Zone episode where helpful aliens leave behind a book called ‘To Serve Man’, only for us to find out later it’s… Read More »2019 weed wrap: The end of the cannabis cycle of cannabis cycles
If you’ve been around this joint for a while, you’ll have seen us arguing folks would be silly to invest in MedMen (MMEN.C) if hanging… Read More »Deathwatch: MedMen (MMEN.C) is cutting out everything but the cancer that is killing it
MedMen (MMEN.C) owns 33 cannabis retail stores across 9 states. The stores have attractive exteriors, but the business inside is ugly. “MedMen reported another quarter… Read More »MedMen (MMEN.C): cannabis catastrophe – 5 red flags everyone should have seen
The cannabis markets are sorely in need of some good news and better business practices. But if there’s a silver lining to all of this… Read More »Gaia Grow Holdings’ (GAIA.V) hemp clean bill of health provides optimism in an industry starving for good news
So the braintrusts over at MedMen (MMEN.C) have devised a new and novel way to staunch their company’s steady and consistent bleeding: they’re going to… Read More »MedMen (MMEN.C) lay offs reveal an even deeper sickness within
Cresco Labs (CL.C) and Origin House (OH.C) have updated the terms of their $1.1B acquisition, repricing the all-stock transaction to match declining share prices since… Read More »Cresco Labs (CL.C) reprices Origin House (OH.C) acquisition terms to match declining market
“Fiscal 2019 was a transformative year for Medmen, with over two million completed retail transactions to date and revenues increasing 227% year-over-year,” said Adam Bierman,… Read More »MedMen (MMEN.C) yearly loss was $1m more than Supreme Cannabis’ (FIRE.T) entire market cap
Sometimes a deal broken is a good deal for shareholders, especially if you give a red rat’s behind about your favourite company having enough money… Read More »Deals being reversed across the board as weed companies discover fiscal responsibility
In late August, Jim Cramer, host of CNBC’s Mad Money program, said he believes Cronos Group (CRON.C), and Aphria (APHA.T) are better investments than Canopy Growth (WEED.T). Cramer pointed to… Read More »Jim Cramer likes Cronos (CRON.C) more than Canopy Growth (WEED.T), but should you?
